中国麻风皮肤病杂志 ›› 2022, Vol. 38 ›› Issue (5): 324-326.doi: 10.12144/zgmfskin202205324

• 病例报告 • 上一篇    下一篇

IL-17A拮抗剂治疗儿童重症银屑病一例

赵晴,刘红,张福仁   

  1. 山东第一医科大学附属皮肤病医院（山东省皮肤病医院），山东省皮肤病性病防治研究所，济南，250022
  • 出版日期:2022-05-15 发布日期:2022-03-15
  • 通讯作者: 张福仁，E-mail: zhangfuren@hotmail.com

Successful treatment of pediatric psoriasis with IL-17A inhibitor monotherapy: a case report

ZHAO Qing, LIU Hong, ZHANG Furen   

  1. Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250022, China
  • Online:2022-05-15 Published:2022-03-15
  • Contact: ZHANG Furen, E-mail: zhangfuren@hotmail.com

PDF (PC)

169

摘要： 患儿，男，4岁。全身反复出现红斑、鳞屑1年，加重2个月。患儿既往体健，无系统疾病史，其母有“银屑病”病史。皮肤科检查可见头面部、躯干、四肢大面积鳞屑性斑块，Auspitz's征（+）。实验室检查未见明显异常，诊断为斑块型银屑病。给予IL-17A拮抗剂治疗，4周后，皮损基本消退，仅留有色素沉着。本例患者是迄今使用司库奇尤单抗治疗的年龄最小的斑块型银屑病患者，值得进一步观察。

关键词: 儿童, 斑块型银屑病, 司库奇尤单抗

Abstract: A four-year-old boy presented with erythematous plaques and scales for one year and exacerbated for two months. His mother had a history of psoriasis. Dermatological examination showed erythematous lesions with silvery scaling on his head, face, trunk, and limbs. The diagnosis of plaque psoriasis was made. Secukinumab 150 mg were administrated with a one-week interval, resulting in completely cleared skin after four times treatment. This child is the youngest patient with plaque psoriasis treated with secukinumab and needs further attention.

Key words: child, plaque psoriasis, secukinumab